HIV Citation List:  May 27 – June 09, 2009

Pubmed citations:

1.       Combinations of the first and next generation HIV fusion inhibitors exhibit highly potent synergistic effect against enfuvirtide-sensitive and resistant HIV-1 strains.  Pan C, Cai L, Lu H, Qi Z, Jiang S.  J Virol. 2009 Jun 3. [Epub ahead of print]  PMID: 19493996

2.       "Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence.  Savarino A, Mai A, Norelli S, El Daker S, Valente S, Rotili D, Altucci L, Palamara AT, Garaci E.  Retrovirology. 2009 Jun 2;6(1):52. [Epub ahead of print]  PMID: 19486542

3.       Design of HIV-1 Protease Inhibitors with Pyrrolidinones and Oxazolidinones as Novel P1'-Ligands To Enhance Backbone-Binding Interactions with Protease: Synthesis, Biological Evaluation, and Protein-Ligand X-ray Studies (infinity).  Ghosh AK, Leshchenko-Yashchuk S, Anderson DD, Baldridge A, Noetzel M, Miller HB, Tie Y, Wang YF, Koh Y, Weber IT, Mitsuya H.  J Med Chem. 2009 May 27. [Epub ahead of print]  PMID: 19473017

4.       Design, microwave-assisted synthesis and HIV-RT inhibitory activity of 2-(2,6-dihalophenyl)-3-(4,6-dimethyl-5-(un)substituted-pyrimidin-2-yl)thiazolidin-4-ones.  Chen H, Bai J, Jiao L, Guo Z, Yin Q, Li X.  Bioorg Med Chem. 2009 Jun 1;17(11):3980-6. Epub 2009 Apr 18.  PMID: 19411176

5.       The octadecyloxyethyl ester of (S)-9-[3-hydroxy-2-(phosphonomethoxy) propyl]adenine is a potent and selective inhibitor of hepatitis C virus replication in genotype 1A, 1B, and 2A replicons.  Wyles DL, Kaihara KA, Korba BE, Schooley RT, Beadle JR, Hostetler KY.  Antimicrob Agents Chemother. 2009 Jun;53(6):2660-2. Epub 2009 Mar 16.  PMID: 19289518

6.       2-Phenylquinolones as inhibitors of the HIV-1 Tat-TAR interaction.  Gatto B, Tabarrini O, Massari S, Giaretta G, Sabatini S, Del Vecchio C, Parolin C, Fravolini A, Palumbo M, Cecchetti V.  ChemMedChem. 2009 Jun;4(6):935-8.  PMID: 19283692

ISI Web of Science citations:

7.       Development of a Novel Fusion Inhibitor against T-20-resistant HIV-1.  Oishi, S; Ito, S; Nishikawa, H; Tanaka, M; Ohno, H; Otaka, A; Izumi, K; Kodama, E; Matsuoka, M; Fujii, N.  ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 2009; 611: 389-391.

8.       Anti-HIV dendrimeric peptides.   Yu, QT; Li, L; Tam, JP. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 2009; 611: 539-540. 

9.       Retrocyclin-2: a potent anti-HIV theta-defensin that forms a cyclic cystine ladder structural motif.  Daly, NL; Chen, YK; Rosenren, KJ; Marx, UC; Phillips, ML; Waring, AJ; Wang, W; Lehrer, RI; Craik, DJ.  ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 2009; 611: 577-578. 

10.   Efficacy of dinitrochlorobenzene and 3 '-azido-3 '-deoxythymidine for treating acquired immunodeficiency disease.  Urso, P; Goldberg, B; DeLancie, R; Margulis, SB.  LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2009; 5(3): 41-49.

11.   Effectiveness of commercial inhibitors against subtype F HIV-1 protease.  Krauchenco, S; Martins, NH; Sanches, M; Polikarpov, I.  JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2009; 24(3): 638-645.

12.   Screening for NNRTIs with Slow Dissociation and High Affinity for a Panel of HIV-1 RT Variants.  Elinder, M; Nordstrom, H; Geitmann, M; Hamalainen, M; Vrang, L; Oberg, B; Danielson, UH. JOURNAL OF BIOMOLECULAR SCREENING, 2009; 14(4): 395-403. 

13.   Soluble CD4 and CD4-Mimetic Compounds Inhibt HIV-1 Infection by Induction of a Short-Lived Activated State.  Haim, H; Si, ZH; Madani, N; Wang, LP; Courter, JR; Princiotto, A; Kassa, A; DeGrace, M; McGee-Estrada, K; Mefford, M; Gabuzda, D; Smith, AB; Sodroski, J.  PLOS PATHOGENS, 2009; 5(4): e1000360.

14.   4-Thio-uridylate (UD29) interferes with the function of protein -SH and inhibits HIV replication in vitro.  Beck, Z; Kis, A; Berenyi, E; Kovacs, P; Fesus, L; Aradi, J.  PHARMACOLOGICAL REPORTS, 2009; 61(2): 343-347.

15.   Discovery of Wild-Type and Y181C Mutant Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors Using Virtual Screening with Multiple Protein Structures.  Nichols, SE; Domaoal, RA; Thakur, VV; Tirado-Rives, J; Anderson, KS; Jorgensen, WL.  JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2009; 49(5): 1272-1279.